Tau – Discover Pharma

Welcome to Discover Pharma! Today is : October 13, 2026

Tau

Central Nervous System,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Amyl Therapeutics raises €8.25M to advance pan-amyloid neurodegenerative disease platform
Amyl Therapeutics has raised €8.25m to generate preclinical data for [...]

September 14, 2026
Central Nervous System,Drug Discovery & Development,Research & Development,Therapeutic Areas
$3M funding targets tau-driven neurodegenerative diseases
A $3m research programme will fund four projects investigating the [...]

September 14, 2026
Central Nervous System,Genomics and sequencing,Research & Development,Therapeutic Areas
Alamar expands Alzheimer’s proteomics partnership with 86,000 more samples
Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]

August 12, 2026
Advanced Therapies,Central Nervous System,Drug Discovery & Development
$2.5M awarded to fuel breakthrough research into tau-driven neurodegenerative diseases
The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer’s Association, and [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK